However, it is noteworthy that for the skin, drugs targeting AhR have been developed for the treatment of atopic dermatitis, an allergic disease characterized by a type 2 cytokine profile and recently described as elicited by pollutants through AhR [104]. The gene discussed is AHR; the disease is allergic disease.